Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Subjects:

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

Subjects:

Inclusion criteria. by Heloisa Ricci Conesa (18291210)

Subjects:

Frequency (%) of PCV-serotypes identified between 2011–2021 by testing source and country. by Heloisa Ricci Conesa (18291210)

Subjects:

Penicillin non-susceptibility¹ of S. pneumoniae over time, by country and sample size [11, 12, 60, 66, 68–73, 75–77, 79–86]. by Heloisa Ricci Conesa (18291210)

Subjects:

The number of studies with data for each of the included countries. by Heloisa Ricci Conesa (18291210)

Subjects:

Time trends of changes in AOM hospitalization incidence rates. by Heloisa Ricci Conesa (18291210)

Subjects:

Number of papers included by year and outcome category. by Heloisa Ricci Conesa (18291210)

Subjects:

Dissociation of peptide-MHC-II complex on the live cells. by Koushik Roy (193484)

Scatter plot for the absolute decrease in CS rates (A) and the relative decrease in CS rates (B) from 2008 to 2016 among hospitals in Guangzhou grouped by their baseline CS rates. by Xiaoyan Xia (560153)

“…One circle represents one hospital, with blue (<i>n</i> = 20), green (<i>n</i> = 36), orange (<i>n</i> = 34), and purple (<i>n</i> = 22) representing baseline CS rates of <30%, 30%–39%, 40%–49%, and ≥50%, respectively. The absolute decrease = the CS rate at baseline − the CS rate in Stage 2; the relative decrease = (the CS rate at baseline − the CS rate in Stage 2) ÷ the CS rate at baseline. …”

Sensitivity analysis heatmap for perturbations of 1%, 10%, and 50% in optimized parameters with Covid-19 data in Brazil. by Hélder Seixas Lima (18840636)

Effects of a DCL on the number of 50-kHz USVs induced by rhythmic stroking. by Rie Shimoju (20940045)

Fig 2 - by Lukas E. Brümmer (11269299)

Subjects:

Ivermectin significantly decreases <i>L</i>. <i>loa</i> mf in BALB/c mice. by Rene Bilingwe Ayiseh (6900296)

Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

PRISMA flow diagram. by Lukas E. Brümmer (11269299)

Subjects:

PKCε activation induces aggrecan gene expression, decreases ADAMTS5, and detection of ADAMTS-5-depended cleavage of ECM aggrecan through upregulation of hsa-miR-377 expression. by Emmanouella Tsirimonaki (490707)

“…<p>(<b>A</b>) RT-PCR detected the relative expression of ACAN, MKI67, ADAMTS5 after treatment of NP cells with 1 μM ψεRACK (or vehicle) for indicated times and revealed that time-dependent activation of PKCε significantly increased the mRNA expression for aggrecan, while in an opposing manner decreased ADAMTS5; mRNA levels of the proliferation marker Ki67 became barely detectable after 8 hours of PKCε activation. …”

Scallop fishery landings from RCP8.5 (top panel) and RCP4.5 (bottom panel) under the highest management strategy (catch limits, variable reference points, and 10% area closure) with varying ocean acidification impacts: Decreased larval survival (L), reduced growth rates (L+G), and increased predation on small scallops (L+G+P). by Jennie E. Rheuban (735526)

<i>btuE</i> expression results in decreased intracellular ROS. by Felipe A. Arenas (23050)

Intake and digestibility during two digestibility trials (1: 20–28 d; 2: 50–56 d) of dairy calves fed different additives in the starter feed (n = 15). by Luisa F. L. Salazar (6664121)